GILEAD SCIENCES DL-001/ US3755581036 /
9/26/2024 7:06:52 PM | Chg. -0.5700 | Volume | Bid7:12:49 PM | Ask7:12:49 PM | Market Capitalization | Dividend Y. | P/E Ratio |
---|---|---|---|---|---|---|---|
74.1000EUR | -0.76% | 100 Turnover: 7,410 |
73.9900Bid Size: 750 | 74.0600Ask Size: 750 | 92.51 bill.EUR | - | - |
Fundamentals
FY 2023 | Growth (1Y) | |
---|---|---|
Per Share | ||
Earnings per Share: | 4.54 USD | 24.04% |
EPS Diluted: | 4.50 USD | 23.63% |
Revenues per Share: | 21.76 USD | -0.52% |
Book Value per Share: | 18.26 USD | 7.36% |
Cash Flow per Share: | 6.43 USD | -11.67% |
Dividend per Share: | 3.00 USD | 2.74% |
Total | in mill. | |
Revenues: | 27,116.00 USD | -0.60% |
Net Income: | 5,665.00 USD | 23.37% |
Operating Cash Flow: | 8,006.00 USD | - |
Cash and Cash Equivalents: | 6,085.00 USD | - |
Valuation Ratios
Current | Latest FY* | |
---|---|---|
P/E Ratio: | 18.21 | 17.84 |
P/S Ratio: | 3.80 | 3.72 |
P/BV ratio: | 4.53 | 4.44 |
P/CF Ratio: | 12.86 | 12.61 |
PEG: | 0.76 | 0.74 |
Earnings Yield: | 5.49% | 5.60% |
Dividend Yield: | 3.63% | 3.70% |
Market Capitalization | ||
Market Capitalization: | 92.51 bill. EUR | 91.42 bill. EUR |
Free Float Market Cap.: | - EUR | - EUR |
Market Cap. / Employee: | - EUR | - EUR |
Shares Outstanding: | 1.25 bill. |
Profitability
Gross Profit Margin: | 76.04% |
EBIT Margin: | 28.05% |
Net Profit Margin: | 20.89% |
Return on Equity: | 24.90% |
Return on Assets: | 9.12% |
Financial Strength
Liquidity I / Cash Ratio: | 0.54% |
Liquidity II / Quick Ratio: | 0.95% |
Liquidity III / Current Ratio: | 1.43% |
Debt / Equity Ratio: | 1.10% |
Dynam. Debt / Equity Ratio: | 491.83% |
Efficiency
Employees: | - |
Personal Expenses / Employee: | - USD |
Revenues / Employee: | - USD |
Net Income / Employee: | - USD |
Total Assets / Employee: | - USD |
* Fiscal Year End: | 12/31/2023 |
Accounting Standard: | US GAAP |
Currency: | USD |